pyrazolanthrone has been researched along with Astrocytoma, Grade IV in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (75.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aktug, H; Calik-Kocaturk, D; Kose, C; Ozdil, B; Uslu, S | 1 |
| Kayama, T; Kitanaka, C; Narita, Y; Okada, M; Sato, A; Seino, M; Seino, S; Shibui, S; Shibuya, K; Suzuki, S; Watanabe, E | 1 |
| Feng, J; Feng, M; Yan, PF; Zhang, FC; Zhao, HY; Zhao, WH | 1 |
| Chen, G; Gu, B; Gu, PY; Hu, WX; Huang, JY; Li, JY; Li, M; Ren, KW; Wei, D; Xing, B; Zhang, GF | 1 |
4 other study(ies) available for pyrazolanthrone and Astrocytoma, Grade IV
| Article | Year |
|---|---|
JNK Inhibition Modulates the Cytoskeleton, Hypoxia, and Neurogenesis on the Protein Level in Glioblastoma Cells and Astrocytes: An Immunofluorescence Study.
Topics: Actins; Astrocytes; Cytoskeleton; Fluorescent Antibody Technique; Glioblastoma; Humans; Hypoxia; Neurogenesis | 2023 |
JNK contributes to temozolomide resistance of stem-like glioblastoma cells via regulation of MGMT expression.
Topics: Anthracenes; Antineoplastic Agents, Alkylating; Blotting, Western; Dacarbazine; DNA Modification Methylases; DNA Repair Enzymes; Drug Resistance, Neoplasm; Gene Expression Regulation, Neoplastic; Glioblastoma; Humans; MAP Kinase Kinase 4; Neoplastic Stem Cells; Real-Time Polymerase Chain Reaction; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; RNA, Small Interfering; Temozolomide; Tumor Cells, Cultured; Tumor Stem Cell Assay; Tumor Suppressor Proteins | 2014 |
Inhibitor of Nicotinamide Phosphoribosyltransferase Sensitizes Glioblastoma Cells to Temozolomide via Activating ROS/JNK Signaling Pathway.
Topics: Acrylamides; Anthracenes; Apoptosis; Caspases; Cell Line, Tumor; Cell Survival; Cytokines; Dacarbazine; Drug Synergism; Gene Expression Regulation, Neoplastic; Glioblastoma; Humans; MAP Kinase Kinase 4; Mitogen-Activated Protein Kinase 8; Nicotinamide Phosphoribosyltransferase; Piperidines; Reactive Oxygen Species; Signal Transduction; Temozolomide; Tocopherols | 2016 |
SP600125, a JNK inhibitor, suppresses growth of JNK-inactive glioblastoma cells through cell-cycle G2/M phase arrest.
Topics: Anthracenes; Benzimidazoles; Blotting, Western; Brain Neoplasms; CDC2 Protein Kinase; Cell Line, Tumor; Cell Nucleus; Enzyme Inhibitors; Flow Cytometry; Fluorescent Dyes; G2 Phase Cell Cycle Checkpoints; Glioblastoma; Humans; M Phase Cell Cycle Checkpoints; MAP Kinase Kinase 4; Vacuoles | 2012 |